Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

被引：0
|
作者：
Dediu, M. [1 ]
机构：
[1] Inst Oncol Bucharest, Med Oncol Dept, Sos Fundeni 252,Sect 2, Bucharest 022328, Romania
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2008年 / 1卷 / 02期
关键词：
Adjuvant chemotherapy; stage IB; risk factors; NSCLC;
D O I：
10.1007/s12254-008-0015-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Adjuvant chemotherapy is established as a standard of care for resectable non-small cell lung cancer. However, this indication remains controversial for the stage IB as the results of the randomized trials and meta-analysis are obscuring on this issue. Moreover, the updated international guidelines do not prescribe the regular use of this strategy in stage IB. The aim of this paper is to review the current evidences regarding the benefit of adjuvant CT in this setting, and to provide clinical hints, which can lend a helping hand to the clinicians and their patients to take the right decision in this particular scenario.
引用
收藏
页码：61 / 65
页数：5
相关论文
共 50 条
  • [1] Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?
    M. Dediu
    [J]. memo - Magazine of European Medical Oncology, 2008, 1 (2) : 61 - 65
  • [2] Adjuvant Chemotherapy for Patients with Stage IB Non-Small Cell Lung Cancer
    Wang, Jia
    Yue, Yang
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S641 - S642
  • [3] The Role of Adjuvant Chemotherapy in Patients With Stage IB Non-Small Cell Lung Cancer
    Yang, L.
    Li, B.
    Xu, Y.
    Zou, B.
    Fan, B.
    Qin, W.
    Fan, X.
    Zhang, D.
    Wang, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E459 - E459
  • [4] Impact of adjuvant chemotherapy on outcomes in stage IB non-small cell lung cancer.
    Goyal, Gaurav
    Nawal, Lata
    Islam, K. M.
    Silberstein, Peter T.
    Ganti, Apar Kishor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [6] Should Patients with Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
    Wang, J.
    Nan, W.
    Lv, C.
    Yan, S.
    Yang, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S849 - S849
  • [7] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [8] Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer
    Zhang, Pei
    Duan, Jianchun
    Bai, Hua
    Wang, Zhijie
    Gao, Shugeng
    Tan, Fengwei
    Gao, Yushun
    Wang, Xin
    Wan, Rui
    Xu, Jiachen
    He, Xiran
    Feng, Xiaoshuang
    Yu, Ruofei
    Sun, Jing
    Zhao, Zhe
    Fei, Kailun
    Li, Ni
    He, Jie
    Wang, Jie
    [J]. THORACIC CANCER, 2021, 12 (01) : 30 - 39
  • [9] Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis
    Coutinho, D.
    Goncalves, A.
    Antunes, A.
    Campainha, S.
    Miranda, J.
    Barroso, A.
    [J]. REVISTA PORTUGUESA DE PNEUMOLOGIA, 2016, 22 (02) : 123 - 125
  • [10] Adjuvant chemotherapy for early stage non-small cell lung cancer
    Patel, Manali L.
    Wakelee, Heather A.
    [J]. FRONTIERS IN ONCOLOGY, 2011, 1
12345